Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

FDA Approves Device to Treat Brain Cancer

April 18, 2011 6:53 am | by Matthew Perrone | News | Comments

Device maker Novocure said that the Food and Drug Administration approved its first-of-a-kind treatment that fights cancerous brain tumors using electrical energy fields.

TOPICS:

Synthes Confirms J & J Deal Being Discussed

April 18, 2011 6:45 am | by John Heilprin | News | Comments

U.S.-Swiss medical device maker Synthes Inc. confirmed it is in talks to be bought out by health giant Johnson & Johnson, in a deal that could make its chairman Switzerland's richest man.

TOPICS:

Lilly's 1Q Profit Falls 15%

April 18, 2011 6:42 am | by Tom Murphy | News | Comments

Eli Lilly and Co.'s first-quarter profit fell 15 percent because of severance costs and a diabetes drug development agreement designed to help the drugmaker handle a wave of patent expirations for key products.

TOPICS:
Advertisement

Clinical Pharmacology Facility Opens

April 18, 2011 5:55 am | News | Comments

Vince & Associates Clinical Research, Overland Park, Kan., has opened a 90-bed Clinical Pharmacology Research Unit.

TOPICS:

Motorized Stage

April 15, 2011 8:29 am | Product Releases | Comments

The Z Axis Motorized Stage from Prior Scientific offers a wide range of positioning solutions for a variety of applications. Many configurable options are available from a simple motorized linear axis to a full three axis stage system.

TOPICS:

Low Volume Fraction Collector

April 15, 2011 8:24 am | Product Releases | Comments

Zinsser Analytic has developed µFRACS – an automated low volume fraction collector for µHPLC. µFRACS is a rapid and accurate system that quickly collects small fractions of only a few µLs directly into 384-well or 96-well microtiter plates.

TOPICS:

Former Merck CEO Compensation Up 65%

April 15, 2011 8:07 am | by Tom Murphy | News | Comments

Recently retired Merck & Co. CEO Richard Clark saw a 65 percent increase in total compensation last year compared with 2009, when stock price fluctuations reduced stock and option awards given to the drugmaker's top executives.

TOPICS:

Tofacitinib Meets Primary Endpoints of ORAL Scan

April 15, 2011 8:04 am | News | Comments

Pfizer Inc. announced top-line results from the ORAL Scan Phase 3 study of tofacitinib, formerly known as tasocitinib, an investigational, novel, oral JAK inhibitor.

TOPICS:
Advertisement

Genes That Control Aging Steroid Identified

April 15, 2011 8:00 am | News | Comments

Eight genes which control levels of the main steroid produced by the adrenal gland, believed to play a role in ageing and longevity, have been uncovered by an international consortium of scientists.

TOPICS:

DNA Replication Enzyme Might Be Cancer Drug Target

April 15, 2011 7:58 am | News | Comments

An enzyme essential for DNA replication and repair in humans works in a way that might be exploited as anti-cancer therapy, say researchers at The Scripps Research Institute and Lawrence Berkeley National Laboratory.

TOPICS:

Amylin Announces Metreleptin Study Results

April 15, 2011 7:50 am | News | Comments

Amylin Pharmaceuticals, Inc. announced results from a new analysis of an ongoing, long-term research study of the investigational drug metreleptin, an analog of the human hormone leptin, for the treatment of lipodystrophy.

TOPICS:

CHMP Recommends Bydureon Approval

April 15, 2011 7:46 am | News | Comments

Drugmakers Eli Lilly and Co. and Amylin Pharmaceuticals Inc. said a European committee has endorsed its potential diabetes treatment Bydureon, a key step toward possible approval in the European Union.

TOPICS:

Billion Dollar Drug Dispute Finally Settled

April 15, 2011 7:42 am | News | Comments

Drugmakers Merck and Johnson & Johnson said they've reached a deal to end a multibillion dollar arbitration dispute over rights to two lucrative drugs for immune disorders.

TOPICS:

J & J Issues Another Recall

April 15, 2011 7:40 am | by Linda A. Johnson | News | Comments

Johnson & Johnson issued yet another recall , this one for about 57,000 bottles of a widely used epilepsy pill, due to complaints of a chemical odor. The health care giant said it is recalling two lots of 100-milligram tablets of Topamax.

TOPICS:

Genome-Wide Array

April 14, 2011 8:09 am | Product Releases | Comments

Affymetrix, Inc. launched the Axiom Genome-Wide CHB 1 Array, the first commercial product to maximize genetic coverage of common alleles in Han Chinese populations. This array is the third population-designed array for the Axiom Genotyping Solution.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading